Rhythm Pharmaceuticals buy Royal Bank of Canada
Start price
18.02.26
/
50%
€84.50
Target price
18.02.27
-
Performance (%)
7.10%
Price
05.08.26
€90.50
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 7.10%. This prediction currently runs until 18.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | -2.162% | -2.162% |
| iShares Core DAX® | 3.153% | 1.504% |
| iShares Nasdaq 100 | 7.431% | -1.584% |
| iShares Nikkei 225® | 8.571% | -4.324% |
| iShares S&P 500 | 4.578% | 1.920% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€96.00
05.08.26
05.08.26
€134.35
05.08.27
05.08.27
0.00%
05.08.26
05.08.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€100.00
07.07.26
07.07.26
-
07.07.27
07.07.27
-4.00%
05.08.26
05.08.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€81.00
06.05.26
06.05.26
€116.89
06.05.27
06.05.27
18.52%
05.08.26
05.08.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.50
17.03.26
17.03.26
€113.07
17.03.27
17.03.27
23.87%
05.08.26
05.08.26